DeviceTalks News

21
Aug

Can Fractyl Labs and Cala Health go where only drugs have gone before?

In this week’s DeviceTalks Weekly podcast, co-costs Tom Salemi and Chris Newmarker walk through this week’s “Newmarker’s Newsmakers,” the Top Five #medtech stories of the week with news coming from CureVac, Avail Medsystems, ClearMask, Thermo Fisher and Bayer.

We also hear from CEO Harith Rajagopalan, MD and CFO Lisa Davidson of Fractyl Laboratories, which is making great strides in developing a device to treat diabetes.

Cala Health CEO Renee Ryan returns to the podcast to give us an update on the Cala Trio’s clinical success in reducing essential tremors and how the start-up is working through COVID-19.

Finally, Chris and Tom hint at an upcoming event for the DTW community.

Subscribe today on Apple Podcasts, Spotify, and other players.

Leave a Reply